Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Downgrades Itron to Perform

Oppenheimer analyst Noah Kaye downgrades Itron (NASDAQ:ITRI) from Outperform to Perform.

byBenzinga Newsdesk

October 6, 2021

1 minute read

Oppenheimer analyst Noah Kaye downgrades Itron (NASDAQ:ITRI) from Outperform to Perform.

Merck Shows Takeover Interest In Seagen: WSJ

By Vandana Singh

Today, 3:22 AM

Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the…

MRK

Morgan Stanley Initiates Coverage On Cenovus Energy with Overweight Rating, Announces Price Target of C$18

By Benzinga Newsdesk

Today, 3:22 AM

Morgan Stanley analyst Devin McDermott initiates coverage on Cenovus Energy (TSX:CVE) with a Overweight rating and announces Price Target of C$18.

TSX:CVE

Pacific Biosciences Q3 EPS $0.08 Up From $(0.14) YoY, Sales $34.90M Beat $33.23M Estimate

By Benzinga Newsdesk

Today, 3:22 AM

Pacific Biosciences (NASDAQ:PACB) reported quarterly earnings of $0.08 per share. This is a 157.14 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales

PACB

Wall Street Journal Reports Didi Global Considers Going Private

By Charles Gross

Today, 3:22 AM

https://www.wsj.com/articles/didi-global-considers-going-private-to-placate-china-and-compensate-investors-11627551071

DIDI

Oppenheimer Downgrades Itron to Perform

Related Posts

Merck Shows Takeover Interest In Seagen: WSJ

Morgan Stanley Initiates Coverage On Cenovus Energy with Overweight Rating, Announces Price Target of C$18

Pacific Biosciences Q3 EPS $0.08 Up From $(0.14) YoY, Sales $34.90M Beat $33.23M Estimate

Wall Street Journal Reports Didi Global Considers Going Private